
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Emily Falk, Professor of Communications, Psychology, and Marketing at the University of Pennsylvania, about her new book, "What We Value... The Neuroscience of Choice and Change."
Then, Jeff Liter, Founder and CEO of Luminary Therapeutics, shares how new developments in cell therapy could make treatments for cancer and autoimmune diseases more affordable and accessible, without needing to be personalized for each patient.

21,957 Listeners

43,907 Listeners

32,033 Listeners

38,484 Listeners

6,795 Listeners

43,615 Listeners

27,162 Listeners

2,875 Listeners

9,197 Listeners

464 Listeners

722 Listeners

943 Listeners

6,412 Listeners

922 Listeners

101 Listeners